Accelerate@Babraham, the Babraham Research Campus’ programme supporting early-stage life science ventures, announces new cohort
Specialist preclinical contract research organisation (CRO) Cellomatics Biosciences has launched a new in vitro model of the blood brain barrier (BBB) for research into neurodegenerative diseases.
London and Oxford, UK, 15 May 2023 – Self funded, not-for-profit medical research organisation LifeArc and techbio company PrecisionLife announce a strategic R&D collaboration to accelerate the discovery and development of targeted treatments for motor neuron disease (MND) - also known as amyotrophic lateral sclerosis (ALS), and Lou Gehrig's disease.
The go-to-market strategies deployed by emerging biotechs to launch their first products into Europe have changed in the last two years.
Instead of building their own infrastructure, emerging biotechs are primarily commercialising their products through out-licencing, partnerships or global biopharma buy-outs.
To hear more about the findings, please read the latest report by the Deloitte Life Sciences Catalyst team.
Source LDPath’s outstanding digital integration with East Kent Hospital NHS Foundation Trust (EKHUFT) pathology department has been selected as the winner of the “Best Hospital Technology Implementation” award in the 7th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough.
o2h group, the creators of innovative SciTech communities, has launched the Cambridge Wide Open Day, offering a unique insight into the city best known as the ‘UK Centre of Science & Technology’. The inaugural event will take place on Wednesday 14 June 2023, welcoming science enthusiasts and local residents alike from across the Cambridge community – giving everyone the opportunity to explore the city’s world-class science and technology facilities all in one day.